pharmacokinetics,
Showing 1 - 2 of 2
Metastatic Castrate-Resistant Prostate Cancer (mCRPC),, Efficacy,, Safety and Tolerability, Trial in United Kingdom, United
Completed
- Metastatic Castrate-Resistant Prostate Cancer (mCRPC),
- +5 more
- Intermittent dosing of AZD5363
-
Sarasota, Florida
- +7 more
Jun 18, 2014